To include your compound in the COVID-19 Resource Center, submit it here.

Thalomid thalidomide: Phase II

Interim results from a Phase II trial showed that 77 percent of of

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE